Geoffrey Boyce is the CEO of Array Behavioral Care, the leading telepsychiatry service provider in the U.S., with a mission to transform access to quality behavioral health care. Boyce is a leader in telemedicine advocacy, education and reform initiatives. He serves as a national voice promoting telemedicine and telepsychiatry and regularly interacts with state and local healthcare regulators and administrators. Boyce is an active participant in several ATA Special Interest Groups and Workgroups including: the Telemental Health SIG, the Interstate SIG, the controlled substances prescribing and telehealth workgroup and the proposed workgroup on the expatriate telemedicine providers. He also serves on the advisory board of directors for the Mid-Atlantic Telehealth Resource Center (MATRC). Boyce frequently speaks about the potential of telemedicine and the best practices for establishing new programs.
In some ways, the Drug Enforcement Agency’s (DEA) proposed rules for prescribing controlled substances via telemedicine are a sign of progress. Behavioral health could be getting some much-needed clarity, but at what cost?